Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion
Open Access
- 1 July 1993
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 106 (1), 1-10
- https://doi.org/10.1016/s0022-5223(19)33735-3
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The response of human platelets to activated components of the complement systemImmunology Today, 1991
- Influence of human plasma kallikrein on lysosomal enzyme release from polymorphonuclear leukocytesInflammation Research, 1991
- Low dose Aprotinin as blood saver in open heart surgeryEuropean Journal of Cardio-Thoracic Surgery, 1991
- High-Dose Aprotinin: Hemostatic Effects in Open Heart OperationsThe Annals of Thoracic Surgery, 1989
- Platelet preservation during cardiopulmonary bypass with aprotininEuropean Journal of Cardio-Thoracic Surgery, 1989
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.Circulation, 1980
- Complement activation during cardiopulmonary bypassAnaesthesia, 1980
- Inhibition of kinin formation by a kallikrein inhibitor during extracorporeal circulation in open-heart surgery.Circulation, 1975